S-Adenosylmethionine 1,4-Butanedisulfonate (CAS 200393-05-1): Your Trusted Pharmaceutical Intermediate Supplier

Discover the critical role of high-purity S-Adenosylmethionine 1,4-Butanedisulfonate (CAS 200393-05-1) as a key pharmaceutical intermediate. As a leading manufacturer and supplier in China, we provide reliable access to this essential compound for your research and development needs, supporting advancements in liver health, osteoarthritis treatment, and cancer research.

Get a Quote & Sample

Key Advantages of Our S-Adenosylmethionine 1,4-Butanedisulfonate

Exceptional Purity for Critical Applications

We deliver S-Adenosylmethionine 1,4-Butanedisulfonate with a minimum purity of 99%, ensuring its efficacy and reliability in sensitive pharmaceutical research and formulation. When you need to buy quality, our product delivers.

Direct Manufacturer Sourcing from China

Benefit from a streamlined supply chain by purchasing directly from our manufacturing facilities in China. This ensures competitive pricing and direct quality control for CAS 200393-05-1.

Comprehensive Product Documentation

We provide essential documentation, including COA and MSDS, to support your quality assurance and regulatory compliance when you purchase our pharmaceutical intermediates.

Key Applications and Research Areas

Liver Health and Disease Research

Explore the potential of S-Adenosylmethionine 1,4-Butanedisulfonate in treating liver conditions and supporting liver regeneration. Purchase for your research needs from a trusted supplier.

Osteoarthritis Treatment Studies

Investigate the compound's efficacy in managing osteoarthritis symptoms, offering a significant avenue for new treatment development. Inquiry about its availability and price.

Cancer Therapy Research

Understand its roles in anti-proliferation, pro-apoptotic, and anti-metastatic effects in various cancer cell lines. Contact us to buy for your oncology research.

Antidepressant and Neurological Applications

Discover its potent antidepressant effects and potential in addressing neurological disorders, making it a compound of interest for pharmaceutical R&D.